Restoring retinal neurovascular health via SUBSTANCE P (cas 12769-48-1)
-
Add time:08/29/2019 Source:sciencedirect.com
Regulation of vascular permeability plays a major role in the pathophysiology of visually threatening conditions such as retinal vein occlusion and diabetic retinopathy. Principally, several factors such as vascular endothelial growth factor (VEGF), are up-regulated or induced in response to hypoxia thus adversely affecting the blood-retinal barrier (BRB), resulting in retinal edema and neovascularisation. Furthermore, current evidence supports a dysregulation of the inner retinal neural-vascular integrity as a critical factor driving retinal ganglion cell (RGC) death and visual loss. The principal objective of this study was to interrogate whether Substance P (SP), a constitutive neurotransmitter of amacrine and ganglion cells, may protect against N-methyl-d-aspartate (NMDA)-induced excitotoxic apoptosis of ganglion cells and VEGF-induced vessel leakage in the retina. Tight junctional protein expression and a Vascular Permeability Image Assay were used to determine vascular integrity in vitro. The protective effect of SP on RGC was established in ex vivo retinal explants and in vivo murine models. After NMDA administration, a reduction in TUNEL+ cells and a maintained number of Brn-3a+ cells were found, indicating an inhibition of RGC apoptosis mediated by SP. Additionally, SP maintained endothelial tight junctions and decreased VEGF-induced vascular permeability. In conclusion, administration of SP protects against NMDA apoptosis of RGC and VEGF-induced endothelial barrier breakdown.
We also recommend Trading Suppliers and Manufacturers of SUBSTANCE P (cas 12769-48-1). Pls Click Website Link as below: cas 12769-48-1 suppliers
Prev:SUBSTANCE P (cas 12769-48-1) plays a critical role in synaptic transmission in striatal neurons
Next:SUBSTANCE P (cas 12769-48-1) improves MSC-mediated RPE regeneration by modulating PDGF-BB) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- SUBSTANCE P (cas 12769-48-1)☆09/04/2019
- PEGylated SUBSTANCE P (cas 12769-48-1) augments therapeutic angiogenesis in diabetic critical limb ischemia09/03/2019
- News and reviewsRole of SUBSTANCE P (cas 12769-48-1) in the cardiovascular system09/02/2019
- SUBSTANCE P (cas 12769-48-1)-mediated cardiac mast cell activation: An in vitro study09/01/2019
- PreviewSUBSTANCE P (cas 12769-48-1) and Inflammatory Pain: Getting It Wrong and Right Simultaneously08/31/2019
- SUBSTANCE P (cas 12769-48-1) improves MSC-mediated RPE regeneration by modulating PDGF-BB08/30/2019
- SUBSTANCE P (cas 12769-48-1) plays a critical role in synaptic transmission in striatal neurons08/28/2019
- ReviewSUBSTANCE P (cas 12769-48-1) in cardiovascular diseases – A bioanalytical review08/27/2019
- News and reviewsSUBSTANCE P (cas 12769-48-1) and fibrotic diseases08/26/2019
-
Health and Chemical more >


